用量子核学习提升药物活性预测准确率
Q2SAR: A Quantum Multiple Kernel Learning Approach for Drug Discovery
- 融合量子与经典核函数，优化分子分类模型
- 在DYRK1A抑制剂数据集上AUC优于传统方法
- 适合对量子机器学习感兴趣的药学研究者
定量构效关系（QSAR）建模是计算药物发现的核心。本研究成功将量子多重核学习（QMKL）框架应用于增强QSAR分类，显著优于经典方法。研究以识别DYRK1A激酶抑制剂的数据集为例，流程包括将SMILES表示转为数值分子描述符，通过主成分分析（PCA）降维，并使用支持向量机（SVM）训练由多个量子和经典核函数优化组合而成的模型。与经典梯度提升模型对比，量子增强方法在分类任务中取得更高AUC值，表明其在复杂化学信息学分类任务中具备潜在量子优势。
原文摘要 · Abstract (English)
Quantitative Structure-Activity Relationship (QSAR) modeling is a cornerstone of computational drug discovery. This research demonstrates the successful application of a Quantum Multiple Kernel Learning (QMKL) framework to enhance QSAR classification, showing a notable performance improvement over classical methods. We apply this methodology to a dataset for identifying DYRK1A kinase inhibitors. The workflow involves converting SMILES representations into numerical molecular descriptors, reducing dimensionality via Principal Component Analysis (PCA), and employing a Support Vector Machine (SVM) trained on an optimized combination of multiple quantum and classical kernels. By benchmarking the QMKL-SVM against a classical Gradient Boosting model, we show that the quantum-enhanced approach achieves a superior AUC score, highlighting its potential to provide a quantum advantage in challenging cheminformatics classification tasks.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品；中文卡片由大模型生成，请以原文为准。